Alli, a popular over-the-counter weight loss drug, is being recalled in the United States and Puerto Rico because of possible tampering.
According to GlaxoSmithKline (GLAXF), the British company that makes Alli, “A range of tablets and capsules of various shapes and colors were reported to be found inside bottles…Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.”
The tampering was reported in a statement Thursday, which came after customers in seven states complained. GlaxoSmithKline spokeswoman Deborah Bolding said that 20 tampered bottles were reported to the company by 12 customers. The questionable Alli was purchased in retail stores in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas.
Bolding said, ”We have received no reports of serious illness from the consumers who have reported these tampered products.” She did not say whether anyone had actually consumed the fake pills.
Back in 2010, the FDA warned that a counterfeit version of Alli that was being sold online was potentially harmful to dieters. GlaxoSmithKline describes authentic Alli as a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat,” which is the active compound that prevents the absorption of fat.1
The company will be conducting an investigation with the Food and Drug Administration to determine what ingredients are in the tampered products.